Recent Quotes (30 days)

You have no recent quotes
chg | %

IntelGenx Technologies Corp.  

(Public, OTCMKTS:IGXT)   Watch this stock  
Find more results for OTC:IGXT
-0.019 (-2.46%)
Delayed:   1:04PM EDT
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.74 - 0.78
52 week 0.55 - 1.09
Open 0.74
Vol / Avg. 28,769.00/65,594.00
Mkt cap 61.93M
P/E     -
Div/yield     -
EPS -0.02
Shares 66.84M
Beta 0.42
Inst. own     -

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin -59.15% -22.61%
Operating margin -54.44% -18.79%
EBITD margin - -9.00%
Return on average assets -24.20% -10.87%
Return on average equity -52.64% -22.46%
Employees 12 -
CDP Score - -


6420 Abrams St
+1-514-3317440 (Phone)

Website links


IntelGenx Technologies Corp is a Canada-based drug delivery company focused on the development of oral immediate-release and controlled-release products and on developing pharmaceutical products based on its drug delivery technologies. Its product development efforts are based upon over three delivery platform technologies, such as VersaFilm, an oral film technology; VersaTab, a multilayer tablet technology, and AdVersa, a mucoadhesive tablet technology. The VersaFilm technology consists of a thin (25 to 35 micron) polymeric film consisting of the United States Pharmacopeia (USP) components for use in food, pharmaceutical and cosmetic products. Its Multilayer Tablet platform technology allows for the development of oral controlled-release products. Its product portfolio includes INT0001/2004, INT0004/2006, INT0007/2006, INT0008/2007, INT0010/2006, INT0027/2011, INT0030/2011, INT0036/2013, INT0037/2013, INT0039/2013, INT0040/2014, INT0041/2015, INT0042/2015 and INT0043/2015.

Officers and directors

J. Bernard Boudreau QC Vice Chairman of the Board, Independent Director
Age: 70
Andre Godin CPA Chief Financial Officer, Executive Vice President
Ingrid Zerbe Director - Finance and Administration, Corporate Secretary
Age: 60
Robert Bechard Vice President - Corporate Development
Nadine Paiement Vice President - Research & Development
Edward Miller Director - Investor Relations and Corporate Communications
Horst G. Zerbe Ph.D. Chairman of the Board, President, Chief Executive Officer
Age: 68
Clemens Mayr Director
Age: 47
Mark H. Nawacki Director
John Marinucci Independent Director
Age: 60